Background Delay in implementing new treatments into clinical practice results in considerable health and economic opportunity costs. Data from the UK TOBY Cooling Register provides the opportunity to examine how one new effective therapy for newborn infants suspected of suffering asphyxial encephalopathy – therapeutic hypothermia- was implemented in the UK. Methodology/Principal Findings We analysed returned data forms from inception of the Register in December 2006 to the end of July 2011. Data forms were received for 1384 (67%) of the 2069 infants registered. The monthly rate of notifications increased from median {IQR} 18 {15–31} to 33 {30–39} after the announcement of the results of the recent TOBY trial, and to 50 {36–55} after their publication. This rate further increased to 70 {64–83} following official endorsement of the therapy, and is now close to the expected numbers of eligible infants. Cooling was started at 3.3 {1.5–5.5} hours after birth and the time taken to achieve the target 33–34°C rectal temperature was 1 {0–3} hours. The rectal temperature was in the target range in 83% of measurements. From 2006 to 2011 there was evidence of extension of treatment to slightly less severely affected infants. 278 of 1362 (20%) infants died at 2.9 {1.4–4.1} days of age. The rates of death fell slightly over the period of the Register and, at two years of age cerebral palsy was diagnosed in 22% of infants; half of these were spastic bilateral. Factors independently associated with adverse outcome were clinical seizures prior to cooling (p<0.001) and severely abnormal amplitude integrated EEG (p<0.001). Conclusions/Significance Therapeutic hypothermia was implemented appropriately within the UK, with significant benefit to patients and the health economy. This may be due in part to participation by neonatal units in clinical trials, the establishment of the national Register, and its endorsement by advisory bodies.
References
[1]
Cooksey D (2006) A review of UK health research funding http://www.hm-treasury.gov.uk Available: http://www.hm-treasury.gov.uk/d/pbr06_co？oksey_final_report_636.pdf Accessed: 2012 May 15.
[2]
Gunn AJ, Battin M, Gluckman PD, Gunn TR, Bennet L (2005) Therapeutic hypothermia: from lab to NICU. J Perinat Med 33: 340–346.
[3]
Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, et al. (2005) Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353: 1574–1584.
[4]
Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, et al. (2009) Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 361: 1349–1358.
[5]
Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, et al. (2005) Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365: 663–670.
[6]
Jacobs SE, Morley CJ, Inder TE, Stewart MJ, Smith KR, et al. (2011) Whole-Body Hypothermia for Term and Near-Term Newborns With Hypoxic-Ischemic Encephalopathy: A Randomized Controlled Trial. Arch Pediatr Adolesc Med.
[7]
Simbruner G, Mittal RA, Rohlmann F, Muche R (2010) Systemic hypothermia after neonatal encephalopathy: outcomes of neo.nEURO.network RCT. Pediatrics 126: e771–e778.
[8]
Zhou WH, Cheng GQ, Shao XM, Liu XZ, Shan RB, et al. (2010) Selective head cooling with mild systemic hypothermia after neonatal hypoxic-ischemic encephalopathy: a multicenter randomized controlled trial in China. J Pediatr 157: 367–72, 372.
[9]
Li T, Xu F, Cheng X, Guo X, Ji L, et al. (2009) Systemic Hypothermia Induced within 10 Hours After Birth Improved Neurological Outcome in Newborns with Hypoxic-Ischemic Encephalopathy. Hosp Pract (Minneap ) 37: 147–152.
[10]
Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, et al. (2010) Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 340: c363.
[11]
Jacobs S, Hunt R, Tarnow-Mordi W, Inder T, Davis P (2007) Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev CD003311.
[12]
National Institute for Health and Clinical Excellence (2010) Therapeutic hypothermia with intracorporeal temperature monitoring for hypoxic perinatal brain injury http://www.nice.org.uk/Available: http://guidance.nice.org.uk/IPG347 Accessed: May 2012.
[13]
British Association of Perinatal Medicine (2010) Accessed: 2012 May 15. Position statement on therapeutic cooling for neonatal encephalopathy http://www.bapm.org Available: http://www.bapm.org/publications/documen？ts/guidelines/Position_Statement_Therape？utic_Cooling_Neonatal_Encephalopathy_Jul？y%202010.pdf.
[14]
Evans K, Rigby AS, Hamilton P, Titchiner N, Hall DM (2001) The relationships between neonatal encephalopathy and cerebral palsy: a cohort study. J Obstet Gynaecol 21: 114–120.
[15]
Smith J, Wells L, Dodd K (2000) The continuing fall in incidence of hypoxic-ischaemic encephalopathy in term infants. BJOG 107: 461–466.
[16]
Accessed: 2012 May 15. Office for national statistics, UK (13-7-2011) Births and Deaths in England and Wales, 2010 http://www.ons.gov.uk Available: http://www.ons.gov.uk/ons/rel/pop-estima？te/population-estimates-for-uk-england-a？nd-wales-scotland-and-northern-ireland/m？id-2010-population-estimates/index.html.
[17]
Azzopardi D, Strohm B, Edwards AD, Halliday H, Juszczak E, et al. (2009) Treatment Of Asphyxiated Newborns With Moderate Hypothermia In Routine Clinical Practice: How Cooling Is Managed In The UK Outside A Clinical Trial. Arch Dis Child Fetal Neonatal Ed 94: F260–F264.
[18]
Palisano RJ, Hanna SE, Rosenbaum PL, Russell DJ, Walter SD, et al. (2000) Validation of a model of gross motor function for children with cerebral palsy. Phys Ther 80: 974–985.
[19]
Eliasson AC, Krumlinde-Sundholm L, Rosblad B, Beckung E, Arner M, et al. (2006) The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol 48: 549–554.
[20]
Thompson CM, Puterman AS, Linley LL, Hann FM, van der Elst CW, et al. (1997) The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatr 86: 757–761.
[21]
Cuzick J (1985) A Wilcoxon-type test for trend. Stat Med 4: 87–90.
[22]
Strohm B, Hobson A, Brocklehurst P, Edwards AD, Azzopardi D (2011) Subcutaneous Fat Necrosis After Moderate Therapeutic Hypothermia in Neonates. Pediatrics 128: e450–e452.
[23]
Azzopardi D, Wyatt JS, Cady EB, Delpy DT, Baudin J, et al. (1989) Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatr Res 25: 445–451.
[24]
Thoresen M, Penrice J, Lorek A, Cady EB, Wylezinska M, et al. (1995) Mild hypothermia after severe transient hypoxia-ischemia ameliorates delayed cerebral energy failure in the newborn piglet. Pediatr Res 37: 667–670.
[25]
Gunn AJ, Gunn TR, de Haan HH, Williams CE, Gluckman PD (1997) Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest 99: 248–256.
[26]
Gunn AJ, Gluckman PD, Gunn TR (1998) Selective head cooling in newborn infants after perinatal asphyxia: a safety study. Pediatrics 102: 885–892.
[27]
Azzopardi D, Robertson NJ, Cowan FM, Rutherford MA, Rampling M, et al. (2000) Pilot study of treatment with whole body hypothermia for neonatal encephalopathy. Pediatrics 106: 684–694.
[28]
Regier DA, Petrou S, Henderson J, Eddama O, Patel N, et al. (2010) Cost-effectiveness of therapeutic hypothermia to treat neonatal encephalopathy. Value Health 13: 695–702.
[29]
Kruse M, Michelsen SI, Flachs EM, Bronnum-Hansen H, Madsen M, et al. (2009) Lifetime costs of cerebral palsy. Dev Med Child Neurol 51: 622–628.
[30]
Grosse SD, Krueger KV, Mvundura M (2009) Economic productivity by age and sex: 2007 estimates for the United States. Med Care 47: S94–103.
[31]
Blackmon LR, Stark AR (2006) Hypothermia: a neuroprotective therapy for neonatal hypoxic-ischemic encephalopathy. Pediatrics 117: 942–948.
[32]
Djulbegovic B, Paul A (2011) From efficacy to effectiveness in the face of uncertainty: indication creep and prevention creep. JAMA 305: 2005–2006.
[33]
Glasziou PP, Irwig LM (1995) An evidence based approach to individualising treatment. BMJ 311: 1356–1359.
[34]
Gunn AJ, Wyatt JS, Whitelaw A, Barks J, Azzopardi D, et al. (2008) Therapeutic hypothermia changes the prognostic value of clinical evaluation of neonatal encephalopathy. J Pediatr 152: 55–8, 58.
[35]
Thoresen M, Hellstrom-Westas L, Liu X, de Vries LS (2010) Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia. Pediatrics 126: e131–e139.
[36]
Hallberg B, Grossmann K, Bartocci M, Blennow M (2010) The prognostic value of early aEEG in asphyxiated infants undergoing systemic hypothermia treatment. Acta Paediatr 99: 531–536.
[37]
Shankaran S, Pappas A, McDonald SA, Laptook AR, Bara R, et al. (2011) Predictive Value of an Early Amplitude Integrated Electroencephalogram and Neurologic Examination. Pediatrics 128: e112–e120.
[38]
Iwata O, Iwata S, Thornton JS, De Vita E, Bainbridge A, et al. (2007) “Therapeutic time window” duration decreases with increasing severity of cerebral hypoxia-ischaemia under normothermia and delayed hypothermia in newborn piglets. Brain Res 1154: 173–180.
